Tylenol, Theraflu, NyQuil, and DayQuil
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Cirrito et al. v. GSK Consumer Health, Inc.
23-cv-491, W.D.N.Y.
(June 2023)
TheraFlu Emergen-C and TheraFlu Multi-Symptom Severe Cold
Misleadingly marketing products as if they treat symptoms of coughs and colds
Pending
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing that medicines are decongestants
Allegations: Falsely marketing the products treat nasal congestion
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Misleadingly marketing drink mixes using the phrase “Natural fruit flavor” and images of raspberries when they contain artificial flavoring ingredients
Allegations: False natural claims
Allegations: False natural claims
In November 2020, a class-action lawsuit was filed against GSK Consumer Health for allegedly falsely advertising Benefiber prebiotic powders as “100% Natural” when, according to plaintiffs, the powders contain wheat…
In August 2020, a class-action lawsuit was filed against GlaxoSmithKline Consumer Healthcare for allegedly misleadingly advertising Benefiber Prebiotic Supplement as “100% Natural” when, according to plaintiffs, the company uses a…